Search for Clinical Trial Results

Homologous Wasting Disease - 25 Studies Found
Status | Study |
Completed |
Study Name: Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease Condition: Graft Versus Host Disease Date: 2003-02-05 Interventions:
|
Completed |
Study Name: Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease Condition: Graft Versus Host Disease Date: 2002-03-08 Interventions:
|
Completed |
Study Name: Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract Condition: Graft Versus Host Disease Date: 2003-03-06 Interventions: Drug: beclomethasone dipropionate |
Not yet recruiting |
Study Name: A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation Condition: Graft vs. Host Disease Date: 2016-08-11 Interventions:
|
Recruiting |
Study Name: Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract Condition: Graft Versus Host Disease Date: 2014-06-25 Interventions:
|
Completed |
Study Name: Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease Condition: Graft Versus Host Disease Date: 2002-08-05 Interventions:
|
Active, not recruiting |
Study Name: Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease Condition: Graft vs. Host Disease Date: 2012-10-22 Interventions:
|
Recruiting |
Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin Condition: Graft Vs Host Disease Date: 2017-03-23 Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin. |
Completed |
Study Name: Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT Condition: Graft-Versus-Host Disease Date: 2014-05-13 Interventions: Drug: Cyclosporine Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12 |
Terminated |
Study Name: A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD) Condition: Graft Versus Host Disease Date: 2010-02-08 Interventions: Drug: Rituximab Rituximab 375 mg/m2 IV weekly X 4 doses + Prednisone 1 mg/kg/d |